![Anders Kronborg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anders Kronborg
Vorsitzender bei SYNACT PHARMA AB
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Thomas Jonassen | M | - |
ResoTher Pharma AS
![]() ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors. | - |
Lorenzo Grabau | M | 59 |
Securevalue EEIG
Kinnevik New Ventures AB
![]() Kinnevik New Ventures AB Investment ManagersFinance Kinnevik New Ventures AB. (KNV) is a venture capital subsidiary of Kinnevik AB founded in 1936. The firm is headquartered in Stockholm, Sweden. | 3 Jahre |
Samuel Sjöström | M | 37 |
Kinnevik New Ventures AB
![]() Kinnevik New Ventures AB Investment ManagersFinance Kinnevik New Ventures AB. (KNV) is a venture capital subsidiary of Kinnevik AB founded in 1936. The firm is headquartered in Stockholm, Sweden. | 11 Jahre |
Salvador Escalon | M | 49 | 11 Jahre | |
Jeppe Øvlesen | M | 62 |
ResoTher Pharma AS
![]() ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors. | 8 Jahre |
James Knight | M | - | 3 Jahre | |
Mathew Joseph | M | - |
Kinnevik New Ventures AB
![]() Kinnevik New Ventures AB Investment ManagersFinance Kinnevik New Ventures AB. (KNV) is a venture capital subsidiary of Kinnevik AB founded in 1936. The firm is headquartered in Stockholm, Sweden. | 10 Jahre |
Catherine Mazzacco | F | 59 |
LEO Laboratories Ltd.
![]() LEO Laboratories Ltd. Medical DistributorsDistribution Services Part of LEO Fondet, LEO Laboratories Ltd. is a British dermatology company that aims to improve the lives of people living with a dermatological condition. The company is based in Hurley, UK. LEO Laboratories supplies treatments to people with medical needs in more than 130 countries around the world and strives to positively impact the lives of 125 million people through medical dermatology by 2025. Founded in 1960 and headquartered in Denmark, the company currently employs 6,000 professionals across 60 countries. | - |
Franco Danesi | M | 52 |
Kinnevik New Ventures AB
![]() Kinnevik New Ventures AB Investment ManagersFinance Kinnevik New Ventures AB. (KNV) is a venture capital subsidiary of Kinnevik AB founded in 1936. The firm is headquartered in Stockholm, Sweden. | 10 Jahre |
Akhil Chainwala | M | 36 |
Kinnevik New Ventures AB
![]() Kinnevik New Ventures AB Investment ManagersFinance Kinnevik New Ventures AB. (KNV) is a venture capital subsidiary of Kinnevik AB founded in 1936. The firm is headquartered in Stockholm, Sweden. | 10 Jahre |
Jessica Pedroni | F | 41 |
Kinnevik New Ventures AB
![]() Kinnevik New Ventures AB Investment ManagersFinance Kinnevik New Ventures AB. (KNV) is a venture capital subsidiary of Kinnevik AB founded in 1936. The firm is headquartered in Stockholm, Sweden. | 10 Jahre |
Christopher Bischoff | M | 51 |
Kinnevik New Ventures AB
![]() Kinnevik New Ventures AB Investment ManagersFinance Kinnevik New Ventures AB. (KNV) is a venture capital subsidiary of Kinnevik AB founded in 1936. The firm is headquartered in Stockholm, Sweden. | 11 Jahre |
Imelda Shine | F | 53 |
FB Dermatology Ltd.
![]() FB Dermatology Ltd. Pharmaceuticals: OtherHealth Technology FB Dermatology Ltd. is a med-tech company, which focuses on developing and exploring patented bio-photonic technology using fluorescent light energy to stimulate the skin’s own biological processes and repair mechanisms. Its products include Kleresca acne treatment, Kleresca skin rejuvenation, Kleresca rosacea treatment, and Kleresca pre-post Treasureratment. The company is headquartered in Dublin, Ireland. | - |
Marco Marchetti | M | 59 |
FB Dermatology Ltd.
![]() FB Dermatology Ltd. Pharmaceuticals: OtherHealth Technology FB Dermatology Ltd. is a med-tech company, which focuses on developing and exploring patented bio-photonic technology using fluorescent light energy to stimulate the skin’s own biological processes and repair mechanisms. Its products include Kleresca acne treatment, Kleresca skin rejuvenation, Kleresca rosacea treatment, and Kleresca pre-post Treasureratment. The company is headquartered in Dublin, Ireland. | - |
Domenic Serafino | M | 64 |
FB Dermatology Ltd.
![]() FB Dermatology Ltd. Pharmaceuticals: OtherHealth Technology FB Dermatology Ltd. is a med-tech company, which focuses on developing and exploring patented bio-photonic technology using fluorescent light energy to stimulate the skin’s own biological processes and repair mechanisms. Its products include Kleresca acne treatment, Kleresca skin rejuvenation, Kleresca rosacea treatment, and Kleresca pre-post Treasureratment. The company is headquartered in Dublin, Ireland. | 6 Jahre |
Thomas Boesen | M | - | 3 Jahre | |
Roberto Bellini | M | 44 |
FB Dermatology Ltd.
![]() FB Dermatology Ltd. Pharmaceuticals: OtherHealth Technology FB Dermatology Ltd. is a med-tech company, which focuses on developing and exploring patented bio-photonic technology using fluorescent light energy to stimulate the skin’s own biological processes and repair mechanisms. Its products include Kleresca acne treatment, Kleresca skin rejuvenation, Kleresca rosacea treatment, and Kleresca pre-post Treasureratment. The company is headquartered in Dublin, Ireland. | - |
Sven M. Jacobson | M | - |
ResoTher Pharma AS
![]() ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors. | - |
Thomas Feldthus | M | 64 |
ResoTher Pharma AS
![]() ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors. | - |
Lise Hébert | M | 61 |
FB Dermatology Ltd.
![]() FB Dermatology Ltd. Pharmaceuticals: OtherHealth Technology FB Dermatology Ltd. is a med-tech company, which focuses on developing and exploring patented bio-photonic technology using fluorescent light energy to stimulate the skin’s own biological processes and repair mechanisms. Its products include Kleresca acne treatment, Kleresca skin rejuvenation, Kleresca rosacea treatment, and Kleresca pre-post Treasureratment. The company is headquartered in Dublin, Ireland. | - |
Kirsten Drejer | M | 68 |
ResoTher Pharma AS
![]() ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors. | 7 Jahre |
Björn Westberg | M | 62 | 1 Jahre | |
Henrik Stage | M | - |
ResoTher Pharma AS
![]() ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors. | - |
Kirsten Harting | M | - | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Hans-Holger Albrecht | M | 60 | 5 Jahre | |
Uli Alf Hacksell | M | 74 | - | |
Ariel Eckstein | M | 57 | - | |
Mikael Grahne | M | 71 | 10 Jahre | |
Alejandro Santo Domingo Dávila | M | 47 | 5 Jahre | |
Torbjørn Bjerke | M | 61 | 8 Jahre | |
Kerstin Hasselgren | F | 63 | 2 Jahre | |
Armin G. Seifart | M | - | 1 Jahre | |
Christoph Barchewitz | M | 45 |
Kinnevik New Ventures AB
![]() Kinnevik New Ventures AB Investment ManagersFinance Kinnevik New Ventures AB. (KNV) is a venture capital subsidiary of Kinnevik AB founded in 1936. The firm is headquartered in Stockholm, Sweden. | 4 Jahre |
Stina Andersson | F | 41 |
Kinnevik New Ventures AB
![]() Kinnevik New Ventures AB Investment ManagersFinance Kinnevik New Ventures AB. (KNV) is a venture capital subsidiary of Kinnevik AB founded in 1936. The firm is headquartered in Stockholm, Sweden. | 1 Jahre |
Mikael Larsson | M | 57 |
Kinnevik New Ventures AB
![]() Kinnevik New Ventures AB Investment ManagersFinance Kinnevik New Ventures AB. (KNV) is a venture capital subsidiary of Kinnevik AB founded in 1936. The firm is headquartered in Stockholm, Sweden. | 14 Jahre |
Julian Eccles | M | - | - | |
Nils Thomas von Koch | M | 58 | 1 Jahre | |
Cecilia Lundin | F | 54 |
Kinnevik New Ventures AB
![]() Kinnevik New Ventures AB Investment ManagersFinance Kinnevik New Ventures AB. (KNV) is a venture capital subsidiary of Kinnevik AB founded in 1936. The firm is headquartered in Stockholm, Sweden. | 1 Jahre |
Mathias Pedersen | M | 53 |
Kinnevik New Ventures AB
![]() Kinnevik New Ventures AB Investment ManagersFinance Kinnevik New Ventures AB. (KNV) is a venture capital subsidiary of Kinnevik AB founded in 1936. The firm is headquartered in Stockholm, Sweden. | 1 Jahre |
Martin Lewerth | M | 51 | - | |
Dionisio Romero Paoletti | M | 59 | 1 Jahre | |
Marc Zagar | M | 59 | - | |
Per Henrik Persson | M | 50 |
Kinnevik New Ventures AB
![]() Kinnevik New Ventures AB Investment ManagersFinance Kinnevik New Ventures AB. (KNV) is a venture capital subsidiary of Kinnevik AB founded in 1936. The firm is headquartered in Stockholm, Sweden. | 11 Jahre |
Karl Bo Anders Nilsson | M | 57 | 1 Jahre | |
Maria Christina Brunell Livfors | F | 59 |
Kinnevik New Ventures AB
![]() Kinnevik New Ventures AB Investment ManagersFinance Kinnevik New Ventures AB. (KNV) is a venture capital subsidiary of Kinnevik AB founded in 1936. The firm is headquartered in Stockholm, Sweden. | 8 Jahre |
Donna Cordner | F | 68 | 9 Jahre | |
Terje Kalland | M | 73 | 5 Jahre | |
Lone Veng | M | - |
ResoTher Pharma AS
![]() ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors. | - |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Schweden | 24 | 50,00% |
Luxemburg | 13 | 27,08% |
Dänemark | 7 | 14,58% |
Irland | 5 | 10,42% |
Vereinigtes Königreich | 2 | 4,17% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Anders Kronborg
- Persönliches Netzwerk